ForSight VISION5, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://forsightvision5.com
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02742649
- Locations
- 🇵🇦
Clinica de Ojos Orillac - Calvo, Panama City, Panama
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
- Conditions
- Primary Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 81
- Registration Number
- NCT02537015
- Locations
- 🇺🇸
Sall Medical Research Center, Artesia, California, United States
🇺🇸Total Eye Care, Memphis, Tennessee, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
Bimatoprost Ocular Insert Pharmacokinetic Study
- Conditions
- Healthy Volunteers
- Interventions
- Drug: 13mg Bimatoprost Ocular Insert
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT02444767
- Locations
- 🇺🇸
Sall Medical Research Center, Artesia, California, United States
Survey of Patients Taking IOP-Lowering Eye Drops
- Conditions
- GlaucomaOcular Hypertension
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT02384772
- Locations
- 🇺🇸
ForSight VISION5 Recruitment Referral Center, Menlo Park, California, United States
Dose-Ranging Study of the Bimatoprost Ocular Insert
- Conditions
- Primary Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT02358369
- Locations
- 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸Total Eye Care, Memphis, Tennessee, United States
🇺🇸University of Eye Specialists, Maryville, Tennessee, United States
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
- Conditions
- Primary Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT02143843
- Locations
- 🇺🇸
Scripps Clinic Torrey Pines, La Jolla, California, United States
🇺🇸Sall Medical Research Center, Artesia, California, United States
🇺🇸Coastal Research Associates, Atlanta, Georgia, United States
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
- Conditions
- Primary Open Angle GlaucomaOcular Hypertension
- Interventions
- Drug: VISION5 Product
- First Posted Date
- 2013-09-17
- Last Posted Date
- 2014-12-17
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT01943721
- Locations
- 🇱🇻
Contact ForSight VISION5 for Trial Locations, Contact ForSight VISION5 for Trial Locations, Latvia
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
- Conditions
- Ocular HypertensionPrimary Open-Angle Glaucoma
- Interventions
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 169
- Registration Number
- NCT01915940
- Locations
- 🇺🇸
Ophthalmology Associates PC, Fort Worth, Texas, United States
🇺🇸UNC Kittner Eye Center, Chapel Hill, North Carolina, United States
🇺🇸Scripps Clinic Torrey Pines, La Jolla, California, United States